Overview
Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 27 years’ experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years.
Veristat’s focus on novel drug development has led to success when handling the unknowns that arise across complicated therapeutic areas, such as rare/ultra-rare disease, advanced therapies, oncology, and infectious disease trials. We apply this knowledge base every day to solve any clinical program’s challenges, from the simplest to the most complex. Veristat has assembled an extraordinary team of experts worldwide who have mastered therapeutic development intricacies, enabling sponsors to succeed in extending and saving lives.
Company News
Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation
May 23, 2023
Posted by Veristat, LLC

Company Events
Veristat Webinar | Single-Arm Studies for Use as a Registrational Study in Oncology
Jun 14, 2023
Virtual | Live Webinar

Veristat Webinar | Impact of New Medical Device EU Regulation (MDR) on the Development of Drug-Device Combination Products
Jun 29, 2023
Virtual | Live Webinar
